Clinical trial

Non-interventional Study of Risperidone ISM® in Schizophrenia Patients Hospitalised Due to a Relapse

NCT05480046

Study summary

ClinicalTrials.gov

Non-interventional Study of Risperidone ISM® in Schizophrenia Patients Hospitalised Due to a Relapse

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Risperidone ISM Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2022-10-18

PhaseN/A

Conditions

Schizophreniaverified · MONDO: schizophrenia

Interventions

Risperidone ISMDRUG

Sponsors & collaborators

Rovi Pharmaceuticals Laboratorieslead sponsor

Mapped research locations

MadridSpain3 BarcelonaSpain3 BerlinGermany3 MilanItaly2 BonnGermany2 FunchalPortugal2 LondonUnited Kingdom1 HamburgGermany1 MünchenGermany1 EssenGermany1 LeipzigGermany1 PortoPortugal1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05480046 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.